Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
U Of Michigan Finds Pfizer Site Tenant
by Lisa M. Jarvis
August 2, 2010
| A version of this story appeared in
Volume 88, Issue 31
The University of Michigan has signed its first commercial tenant for the former Pfizer facility in Ann Arbor, Mich., it purchased last year for $108 million. BoroPharm, a boron chemical development and manufacturing business started in 2005 by two Michigan State University professors, has already moved into a specialized, freestanding chemical production building on the site. The university is looking for other companies to move into the 174-acre complex while also considering how its own researchers and students can use the facilities.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter